Unique FISH Patterns Associated with Cancer Progression of Oral Dysplasia
Open Access
- 11 October 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Dental Research
- Vol. 91 (1), 52-57
- https://doi.org/10.1177/0022034511425676
Abstract
Subgroups of patients with oral pre-malignant lesions (OPLs) are at extremely high risk for developing invasive cancer in spite of surgical excision. The objective of this study was to evaluate the utility of specific genes and their associated centromeres as markers to stratify OPLs for their cancer risk. Samples used in this study included 35 oral dysplasia with known outcome and 20 normal oral mucosa. Of the dysplasias, 20 were from an ongoing longitudinal study showing progression. The remaining 15 cases (2 of which progressed) were chosen from the population-based, provincial BC Oral Biopsy Service (OBS). Copy number alterations at EGFR, CEP7, CCND1, and CEP11 were evaluated by fluorescent in situ hybridization (FISH). There was no significant difference in demographics between progressors and non-progressors. Specific FISH profiles at these genes and their corresponding centromeres were associated with progression. High gene gain of CCND1 was associated with an 8-fold elevated risk of progression compared with those with no gain in time-to-progression analysis. Numerical alterations of EGFR and CCND1 and their centromeres might be an effective means for identifying OPLs at risk. Future studies will expand on this analysis and set the stage for application of this approach in routine clinical practice.This publication has 30 references indexed in Scilit:
- EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinomaEuropean Journal of Cancer, 2009
- Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasiasInternational Journal of Cancer, 2009
- Genomic imbalances in precancerous tissues signal oral cancer riskMolecular Cancer, 2009
- Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src InhibitorsJournal of Oncology, 2009
- Targeted therapy in head and neck cancerCancer, 2008
- Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinomaThe Journal of Pathology, 2008
- Intriguing issues of EGFR targeting in head and neck cancerAnnals of Oncology, 2007
- Prognostic Biomarkers in Head and Neck CancerClinical Cancer Research, 2006
- OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysisOral Oncology, 2004
- Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysisHead & Neck, 2002